Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment

被引:16
作者
Archer, T
Palomo, T
McArthur, R
Fredriksson, A
机构
[1] Univ Gothenburg, Dept Psychol, SE-40530 Gothenburg, Sweden
[2] Hosp 12 Octubre, Serv Psiquiatria, E-28041 Madrid, Spain
[3] Pharmacia Upjohn R&D, Kalamazoo, MI USA
[4] Uppsala Univ, Dept Neurosci Psychiat Ulleraker, S-75017 Uppsala, Sweden
关键词
MPTP; C57; Bl/6; mice; neonatal; 6-OHDA; Wistar rats; locomotion; apomorphine; bromocriptine; cabergoline; SKF; 38393; FCE; 23884; quinpirole; 7-OH-DPAT;
D O I
10.1007/BF03033375
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of several dopamine (DA) receptor agonists upon locomotor activity on adult MPTP-treated mice and postnatal 6-hydroxydopamine-(6-OHDA-) treated rats were assessed in ten experiments. C57 BL/6 mice were administered 1-methyl-4-phenyl-1,2,3,6-tetrahy-dropyridine (MPTP, 2 x 40 mg/kg, s.c., 24-hr interval between injections) at 5-months-age, while 1-day old male Wistar rat pups were given intracisternal 6-OHDA (50 mg, once following desipramine, 25 mg/kg). MPTP-treated mice were tested 4-5 weeks following MPTP injections whereas neonatal 6-OHDA rats were tested at 3-months-age. Locomotor activity was measured in respective activity test chambers following acute administration of DA receptor agonists. In MPTP-treated mice, apomorphine failed to elevate locomotor activity but instead further exacerbated (1.0 and 3.0 mg/kg, s.c.) the hypokinesia of these animals while inducing marked increases in control mice. Cabergoline (0.3 mg/kg, s.c.) and bromocriptine (3.0 mg/kg, s.c.) caused dose-specific elevations of locomotion in MPTP and control mice but suppressed activity at the highest doses. Quinpirole (0.2 mg/kg) and 7-hydroxydipropy-laminotetralin (7-OH-DPAT; 300 nmole/kg) increased locomotion in hypokinesic MPTP-treated mice; in control mice, activity was elevated by quinpirole (0.2 and 0.7 mg/kg) and 7-OH-DPAT (100 and 300 nmole/kg), while higher doses suppressed activity. Neither SYF 38393 (1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol) nor FCE 23884 [4-(9,10-didehydro-6-methylergolin-8 beta-yl) methyl-piperazine-2,6-dione] affected locomotor activity. Apomorphine (0.3, 1.0 and 2.0 mg/kg), bromocriptine (3.0 mg/kg) and cabergoline (1.0 mg/kg) stimulated locomotion in sham-operated rats, and to a greater extent in the 6-OHDA-treated rats. Higher dose cabergoline (3.0 mg/kg) induced increased activity of similar extent in sham controls and 6-OHDA treated rats. Activity-enhancing effects of quinpirole (0.2, 0.7 and 2.1 mg/kg) in sham rats were attenuated in 6-OHDA treated rats. Both SKF 38393 (10 mg/kg) and FCE 23884 (0.3 and 1.0 mg/kg) induced locomotor activity increases in 6-OHDA, but not sham, rats. Finally, 7-OH-DPAT (1200 mg/kg) enhanced activity in 6-OHDA rats vs. shams. The effects of the DA agonists are discussed with regard to the putative antihypokinesic effects in MPTP mice and DA-receptor supersensitivity effects in neonatal 6-OHDA rats, pertaining to their more-or-less selective subreceptor profiles.
引用
收藏
页码:95 / 109
页数:15
相关论文
共 71 条
[1]  
ARAI N, 1994, JAPAN J PHARM, V64, P172
[2]   CENTRAL NORADRENALINE DEPLETION ANTAGONIZES ASPECTS OF D-AMPHETAMINE-INDUCED HYPERACTIVITY IN THE RAT [J].
ARCHER, T ;
FREDRIKSSON, A ;
JONSSON, G ;
LEWANDER, T ;
MOHAMMED, AK ;
ROSS, SB ;
SODERBERG, U .
PSYCHOPHARMACOLOGY, 1986, 88 (02) :141-146
[3]   FUNCTIONAL-CHANGES IMPLICATING DOPAMINERGIC SYSTEMS FOLLOWING PERINATAL TREATMENTS [J].
ARCHER, T ;
FREDRIKSSON, A .
DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1992, 18 (3-4) :201-222
[5]  
BELLUZZI JD, 1994, MOVEMENT DISORD, V9, P147, DOI 10.1002/mds.870090204
[6]   PLEUROPULMONARY DISEASE ASSOCIATED WITH DOPAMINE AGONIST THERAPY [J].
BHATT, MH ;
KEENAN, SP ;
FLEETHAM, JA ;
CALNE, DB .
ANNALS OF NEUROLOGY, 1991, 30 (04) :613-616
[7]  
BJORK L, 1991, J PHARMACOL EXP THER, V258, P58
[8]   ACTIONS OF (+/-)-7-HYDROXY-N,N-DIPROPYLAMINOTETRALIN (7-OH-DPAT) ON DOPAMINE SYNTHESIS IN LIMBIC AND EXTRAPYRAMIDAL REGIONS OF RAT-BRAIN [J].
BOOTH, RG ;
BALDESSARINI, RJ ;
MARSH, E ;
OWENS, CE .
BRAIN RESEARCH, 1994, 662 (1-2) :283-288
[9]   D-1 RECEPTOR SUPERSENSITIVITY IN THE RAT STRIATUM AFTER UNILATERAL 6-HYDROXYDOPAMINE LESIONS [J].
BUONAMICI, M ;
CACCIA, C ;
CARPENTIERI, M ;
PEGRASSI, L ;
ROSSI, AC ;
DICHIARA, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 126 (03) :347-348
[10]   CHRONIC PARKINSONISM SECONDARY TO INTRAVENOUS-INJECTION OF MEPERIDINE ANALOGS [J].
DAVIS, GC ;
WILLIAMS, AC ;
MARKEY, SP ;
EBERT, MH ;
CAINE, ED ;
REICHERT, CM ;
KOPIN, IJ .
PSYCHIATRY RESEARCH, 1979, 1 (03) :249-254